Brief: Mabion Signs Expansion Of Production Deal With Novavax
Aug 2 (Reuters) - Mabion SA MABP.WA :
* SIGNS EXPANSION OF PRODUCTION DEAL WITH NOVAVAX
* EXPANSION TAKES PLACE UNDER STATEMENT OF WORKS #8
* STATEMENT OF WORKS #8 INCLUDES CARRYING OUT STABILITY
TESTS ON
SARS COV-2 RS ACTIVE SUBSTANCE
* ORDER IS LONG-TERM AND WILL BE CARRIED OUT OVER THREE YEAR
PERIOD FOR EACH TESTED SERIES
Source text for Eikon: ID:nEM47gnsna
Further company coverage: MABP.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Mabion SA
See all newsBrief: Mabion Signs Annex To Extend Production Agreement With Novavax To End of 2029
Brief: Mabion Signs Deal With Oddifact Sas On Preparing Mabioncd20 For FDA Consultation
Brief: Mabion Q1 Net Loss 9.7 Million Zlotys
Brief: Mabion Signs LoI With Oddifact On Use Of MabionCD20 Drug For Orphan Diseases
Brief: Mabion FY Net Loss 62.6 Million Zlotys